Search research articles
Contact Us
Filters
Showing results (611-620 of 644) with videos related to
Page
of 65
Sort By:
British Journal of Cancer
|
August 4, 2018
Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer
Yoichi Aoki, Kazunori Ochiai, Soyi Lim, et al.
Nature
|
July 22, 2020
Coherent many-body exciton in van der Waals antiferromagnet NiPS<sub>3</sub>
Soonmin Kang, Kangwon Kim, Beom Hyun Kim, et al.
Journal of Gynecologic Oncology
|
May 28, 2009
Validation of a nomogram for predicting outcome of vulvar cancer patients, primarily treated by surgery, in Korean population: multicenter retrospective study through Korean Gynecologic Oncology Group (KGOG-1010)
Mi-Kyung Kim, Jae Weon Kim, Jong-Min Lee, et al.
Journal of Gynecologic Oncology
|
April 12, 2024
Current treatment strategies for ovarian cancer in the East Asian Gynecologic Oncology Trial Group (EAGOT)
Yusuke Kobayashi, Muneaki Shimada, Masato Tamate, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 6, 2020
The whale shark genome reveals how genomic and physiological properties scale with body size
Jessica A Weber, Seung Gu Park, Victor Luria, et al.
Plos One
|
June 27, 2024
Prediction of final pathology depending on preoperative myometrial invasion and grade assessment in low-risk endometrial cancer patients: A Korean Gynecologic Oncology Group ancillary study
Dong-Hoon Jang, Hyun-Gyu Lee, Banghyun Lee, et al.
Autophagy
|
August 9, 2020
LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells
Suyeon Kim, Hanbyoul Cho, Soon-Oh Hong, et al.
Cancer Research
|
July 19, 2017
HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells
Kwon-Ho Song, Chel Hun Choi, Hyo-Jung Lee, et al.
Nature Communications
|
February 8, 2023
Coherent consolidation of trillions of nucleations for mono-atom step-level flat surfaces
Taewoo Ha, Yu-Seong Seo, Teun-Teun Kim, et al.
The Lancet. Oncology
|
March 21, 2021
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
Andrés Poveda, Anne Floquet, Jonathan A Ledermann, et al.
Page
of 65
Search research articles
Search
Showing results (611-620 of 644) with videos related to
Sort By:
Page
of 65
British Journal of Cancer
|
August 4, 2018
Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer
Yoichi Aoki, Kazunori Ochiai, Soyi Lim, et al.
Nature
|
July 22, 2020
Coherent many-body exciton in van der Waals antiferromagnet NiPS<sub>3</sub>
Soonmin Kang, Kangwon Kim, Beom Hyun Kim, et al.
Journal of Gynecologic Oncology
|
May 28, 2009
Validation of a nomogram for predicting outcome of vulvar cancer patients, primarily treated by surgery, in Korean population: multicenter retrospective study through Korean Gynecologic Oncology Group (KGOG-1010)
Mi-Kyung Kim, Jae Weon Kim, Jong-Min Lee, et al.
Journal of Gynecologic Oncology
|
April 12, 2024
Current treatment strategies for ovarian cancer in the East Asian Gynecologic Oncology Trial Group (EAGOT)
Yusuke Kobayashi, Muneaki Shimada, Masato Tamate, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 6, 2020
The whale shark genome reveals how genomic and physiological properties scale with body size
Jessica A Weber, Seung Gu Park, Victor Luria, et al.
Plos One
|
June 27, 2024
Prediction of final pathology depending on preoperative myometrial invasion and grade assessment in low-risk endometrial cancer patients: A Korean Gynecologic Oncology Group ancillary study
Dong-Hoon Jang, Hyun-Gyu Lee, Banghyun Lee, et al.
Autophagy
|
August 9, 2020
LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells
Suyeon Kim, Hanbyoul Cho, Soon-Oh Hong, et al.
Cancer Research
|
July 19, 2017
HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells
Kwon-Ho Song, Chel Hun Choi, Hyo-Jung Lee, et al.
Nature Communications
|
February 8, 2023
Coherent consolidation of trillions of nucleations for mono-atom step-level flat surfaces
Taewoo Ha, Yu-Seong Seo, Teun-Teun Kim, et al.
The Lancet. Oncology
|
March 21, 2021
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
Andrés Poveda, Anne Floquet, Jonathan A Ledermann, et al.
Page
of 65